Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin

Conditions:   Locally Advanced Skin Squamous Cell Carcinoma;   Metastatic Skin Squamous Cell Carcinoma;   Recurrent Skin Squamous Cell Carcinoma Interventions:   Biological: Panitumumab;   Biological: Talimogene Laherparepvec Sponsors:   Rutgers, The State University of New Jersey;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials